Association of Low Serum Bilirubin Concentrations and Promoter Variations in the
Gilbert syndrome
HMOX1
UGT1A1
benign hyperbilirubinemia
bilirubin
heme oxygenase
type 2 diabetes mellitus
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
25 Jun 2023
25 Jun 2023
Historique:
received:
16
05
2023
revised:
19
06
2023
accepted:
21
06
2023
medline:
17
7
2023
pubmed:
14
7
2023
entrez:
14
7
2023
Statut:
epublish
Résumé
Bilirubin has potent biological beneficial effects, protecting against atherosclerosis, obesity, and metabolic syndrome. The aim of this study was to assess serum bilirubin concentrations and (TA)
Identifiants
pubmed: 37445792
pii: ijms241310614
doi: 10.3390/ijms241310614
pmc: PMC10342136
pii:
doi:
Substances chimiques
Bilirubin
RFM9X3LJ49
Glucuronosyltransferase
EC 2.4.1.17
HMOX1 protein, human
EC 1.14.14.18
Heme Oxygenase-1
EC 1.14.14.18
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Ministry of Health
ID : MH CZ-DRO-VFN64165
Organisme : Charles University
ID : Cooperatio Program, research area DIAG
Organisme : European Union
ID : EXCELES LX22NPO5104
Références
J Hepatol. 2021 Dec;75(6):1485-1490
pubmed: 34153399
JAMA. 2007 Sep 26;298(12):1398-400
pubmed: 17895455
Pharmacol Res. 2019 Jul;145:104256
pubmed: 31054312
PLoS One. 2016 Apr 12;11(4):e0153427
pubmed: 27071062
N Engl J Med. 1995 Nov 2;333(18):1171-5
pubmed: 7565971
J Diabetes. 2011 Sep;3(3):217-24
pubmed: 21631904
Front Pharmacol. 2012 Apr 03;3:55
pubmed: 22493581
Clin Chem. 2010 Oct;56(10):1535-43
pubmed: 20693308
Tohoku J Exp Med. 2010 Dec;222(4):265-73
pubmed: 21139377
Physiol Genomics. 2019 Jun 1;51(6):234-240
pubmed: 31074682
Clin Sci (Lond). 2015 Jul;129(1):1-25
pubmed: 25881719
Medicine (Baltimore). 2015 Oct;94(43):e1825
pubmed: 26512585
Med Res Rev. 2020 Jul;40(4):1335-1351
pubmed: 32017160
Trends Mol Med. 2023 Apr;29(4):315-328
pubmed: 36828710
Adv Clin Chem. 2007;43:1-57
pubmed: 17249379
Oxid Med Cell Longev. 2017;2017:9478946
pubmed: 28951772
Atherosclerosis. 2002 Feb;160(2):449-56
pubmed: 11849670
Diabetes Care. 2008 Aug;31(8):1615-20
pubmed: 18443197
Physiol Res. 2017 Apr 5;66(Suppl 1):S11-S20
pubmed: 28379026
Diabetol Metab Syndr. 2021 Dec 7;13(1):143
pubmed: 34876211
Nutr Metab Cardiovasc Dis. 2013 Jan;23(1):31-7
pubmed: 21703835
Antioxidants (Basel). 2021 Dec 15;10(12):
pubmed: 34943103
Front Endocrinol (Lausanne). 2022 Nov 02;13:948338
pubmed: 36407305
Atherosclerosis. 2008 May;198(1):1-11
pubmed: 18343383
Am J Epidemiol. 2010 Sep 15;172(6):631-6
pubmed: 20682519
Free Radic Biol Med. 2004 Oct 15;37(8):1097-104
pubmed: 15451051
Clin Biochem. 2010 May;43(7-8):697-9
pubmed: 20152821
Metabolism. 2013 Jul;62(7):976-85
pubmed: 23414908
J Cardiovasc Risk. 1996 Oct;3(5):459-63
pubmed: 9048262
Front Endocrinol (Lausanne). 2022 Mar 30;12:792795
pubmed: 35432184
Int J Endocrinol. 2020 Jul 29;2020:5681296
pubmed: 32802055
Clin Pharmacol Ther. 2019 Sep;106(3):568-575
pubmed: 30588615
Circ J. 2020 Sep 25;84(10):1779-1785
pubmed: 32848115
Antioxidants (Basel). 2021 Sep 15;10(9):
pubmed: 34573106
Antioxidants (Basel). 2021 Aug 26;10(9):
pubmed: 34572984
Sci Rep. 2016 Jul 21;6:30051
pubmed: 27444220
Hepatology. 2004 Oct;40(4):827-35
pubmed: 15382174
Exp Biol Med (Maywood). 2003 May;228(5):568-71
pubmed: 12709588